AzTrials
AzTrials

Hearing Loss; Post-Dural Puncture Headache; Cesarean DeliveryNCT07697651

Evaluation of Postoperative Hearing Loss After Spinal Anesthesia for Elective Cesarean Section in Pregnant Women

An observational study of Hearing Loss; Post-Dural Puncture Headache; Cesarean Delivery, run by Duzce University at 1 site in Turkey (Türkiye).

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This prospective observational study will evaluate postoperative hearing changes in women undergoing elective cesarean delivery under spinal anesthesia. Pure-tone audiometry will be performed before spinal anesthesia and at the predefined postoperative assessment time. Read more about this study

Who is it for?
Ages 18 years and older, women only
How many people
53 participants
Where
1 siteTurkey (Türkiye)
Study dates
25 Mar 2025to 15 Sep 2026
How long will I take part?
7 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of pregnant women scheduled for elective cesarean delivery under spinal anesthesia at Duzce Unıversıty Medical Faculty Hospital Eligible participants will be enrolled consecutively after providing written informed consent. All participants will undergo routine spinal anesthesia as part of standard clinical care. Pure-tone audiometry will be performed preoperatively and within 48 hours postoperatively. Participants will also be followed for 7 days after spinal anesthesia for the occurrence of post-dural puncture headache.

Who may be able to join

  • • Women aged 18 years or older.
  • Scheduled for elective cesarean delivery.
  • Planned spinal anesthesia.
  • ASA physical status I-II [revise if another ASA range is approved in the protocol].
  • Ability to complete preoperative and postoperative pure-tone audiometry assessments.
  • Provision of written informed consent.

Who cannot join

  • • Pre-existing hearing loss, use of hearing aids, or inability to complete audiometric testing.
  • History of chronic otologic disease, ear surgery, or active ear infection.
  • Contraindication to spinal anesthesia.
  • Conversion to general anesthesia before completion of the protocol assessments.
  • Refusal to participate or withdrawal of consent.
  • [Add any protocol-specific exclusions approved by the ethics committee, such as chronic headache disorder, hypertensive disease of pregnancy, or major perioperative hemorrhage, only if applicable.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Duzce University

    Düzce

Other trials in Turkey (Türkiye)

About this study

This prospective observational study will evaluate postoperative hearing changes in women undergoing elective cesarean delivery under spinal anesthesia. Pure-tone audiometry will be performed before spinal anesthesia and at the predefined postoperative assessment time. The incidence, onset time, and severity of post-dural puncture headache (PDPH) will also be assessed. The study aims to determine whether hearing threshold changes occur after spinal anesthesia and whether these changes are associated with PDPH.

Read the detailed description

Spinal anesthesia is routinely used for elective cesarean delivery. Dural puncture may be associated with cerebrospinal fluid pressure changes that can affect inner-ear fluid dynamics and may result in transient changes in hearing thresholds. Post-dural puncture headache is another clinically relevant complication that may reflect cerebrospinal fluid loss and pressure changes.

Eligible women scheduled for elective cesarean delivery under spinal anesthesia will be enrolled consecutively after providing written informed consent. Spinal anesthesia will be administered according to routine clinical practice, with no additional anesthetic intervention performed for research purposes. Demographic and perioperative variables, including spinal needle gauge, sensory block level, hemodynamic measurements, vasopressor use, and occurrence of post-dural puncture headache, will be recorded. Pure-tone audiometry will be performed before surgery and at the predefined postoperative assessment time. Postoperative hearing thresholds will be compared with baseline values, and their association with post-dural puncture headache will be evaluated.

Keywords
Spinal Anesthesia; Cesarean Section; Pure-Tone Audiometry; Hearing Threshold; Post-Dural Puncture Headache; Obstetric Anesthesia
Medical subject headings
Hearing Loss, Post-Dural Puncture Headache

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pure-Tone Audiometry Hearing Thresholds After Spinal Anesthesia

    The primary outcome is the difference between preoperative and postoperative pure-tone audiometry thresholds at the tested frequencies in each ear. Hearing thresholds will be recorded in decibels hearing level (dB HL), and the change from baseline will be analyzed

    Measured: : Baseline preoperative assessment to postoperative audiometric assessment at 48 hours after spinal anesthesia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2026
  2. Study start25 Mar 2025
  3. Primary completion10 Aug 2026 (estimated)
  4. Study completion15 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
53 participants (estimated)
Target duration
7 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07697651
Sponsor's protocol ID
2024/224
Status last verified
Jul 2026
First submitted
7 Jul 2026
Last updated
13 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Hearing Loss; Post-Dural Puncture Headache; Cesarean Delivery, run by Duzce University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pure-Tone Audiometry Hearing Thresholds After Spinal Anesthesia (time frame: : Baseline preoperative assessment to postoperative audiometric assessment at 48 hours after spinal anesthesia). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in